X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (601) 601
Book Review (153) 153
Publication (40) 40
Book Chapter (8) 8
Magazine Article (8) 8
Newsletter (7) 7
Conference Proceeding (4) 4
Book / eBook (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (500) 500
amantadine (359) 359
humans (335) 335
animals (229) 229
male (149) 149
amantadine - therapeutic use (133) 133
female (125) 125
amantadine - pharmacology (119) 119
pharmacology & pharmacy (117) 117
rats (86) 86
influenza (74) 74
antiviral agents - pharmacology (73) 73
mice (73) 73
adult (72) 72
neurosciences (71) 71
antiviral agents - therapeutic use (69) 69
aged (62) 62
clinical neurology (61) 61
middle aged (61) 61
amantadine - adverse effects (57) 57
parkinson's disease (57) 57
dose-response relationship, drug (52) 52
abridged index medicus (50) 50
antiviral agents (48) 48
memantine (48) 48
health aspects (47) 47
parkinson disease - drug therapy (47) 47
drug therapy (46) 46
virology (46) 46
amantadine - administration & dosage (45) 45
analysis (44) 44
double-blind (44) 44
drugs (42) 42
amantadine - analogs & derivatives (41) 41
biochemistry & molecular biology (41) 41
amantadine - toxicity (40) 40
influenza, human - drug therapy (40) 40
oseltamivir (40) 40
in-vitro (38) 38
antiparkinson agents - therapeutic use (36) 36
cell line (36) 36
care and treatment (35) 35
viruses (35) 35
parkinsons-disease (34) 34
time factors (34) 34
rats, sprague-dawley (33) 33
dogs (32) 32
receptors, n-methyl-d-aspartate - antagonists & inhibitors (32) 32
research (32) 32
ribavirin (32) 32
toxicity (32) 32
influenza, human - prevention & control (31) 31
neurology (31) 31
virus replication - drug effects (31) 31
drug therapy, combination (29) 29
rimantadine (29) 29
levodopa (28) 28
medicine & public health (28) 28
ribavirin - therapeutic use (28) 28
dopamine (27) 27
therapy (27) 27
treatment outcome (27) 27
antiviral activity (26) 26
article (26) 26
infection (26) 26
influenza a virus - drug effects (26) 26
amantadine hydrochloride (25) 25
disease models, animal (25) 25
medicine, general & internal (25) 25
psychiatry (25) 25
efficacy (24) 24
infections (24) 24
influenza a virus (24) 24
zanamivir (24) 24
antiviral agents - adverse effects (23) 23
chemistry, medicinal (23) 23
adolescent (22) 22
movement disorders (22) 22
risk factors (22) 22
virus diseases - drug therapy (22) 22
antiviral agents - administration & dosage (21) 21
antiviral agents - chemistry (21) 21
cells, cultured (21) 21
proteins (21) 21
toxicology (21) 21
virus diseases (21) 21
biomedicine (20) 20
chemistry, multidisciplinary (20) 20
complications and side effects (20) 20
drug interactions (20) 20
inhibition (20) 20
neuroprotection (20) 20
placebo-controlled trial (20) 20
adamantane - analogs & derivatives (19) 19
brain (19) 19
dosage and administration (19) 19
glutamate (19) 19
infectious diseases (19) 19
levodopa - therapeutic use (19) 19
pharmacology/toxicology (19) 19
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (597) 597
Russian (8) 8
French (3) 3
Korean (3) 3
Bulgarian (2) 2
German (2) 2
Italian (2) 2
Spanish (2) 2
Chinese (1) 1
Czech (1) 1
Japanese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 2010, Volume 114, Issue 3, pp. 717 - 727
P>The cellular localization of organic cation transporter (OCT) 1 and OCT2 in isolated brain microvessel endothelial cells from humans, rats, and mice and in... 
blood-brain barrier | N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | organic cation transporter | 1-METHYL-4-PHENYLPYRIDINIUM | N-methyl-4-phenyl-1 | BIOCHEMISTRY & MOLECULAR BIOLOGY | HYPOXIA | NEUROSCIENCES | RENAL PROXIMAL TUBULES | PROTECTS | 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE | 6-tetrahydropyridine | AMANTADINE | MICE | RAT-BRAIN | EXPRESSION | PARKINSONS-DISEASE | Parkinsonian Disorders - physiopathology | Binding, Competitive - physiology | Organic Cation Transport Proteins - metabolism | Rats, Wistar | Endothelial Cells - metabolism | Humans | Mice, Inbred C57BL | Cells, Cultured | Rats | Male | Organic Cation Transporter 2 | Blood-Brain Barrier - metabolism | Parkinsonian Disorders - metabolism | Biological Transport, Active | Animals | Capillaries - cytology | Dopamine - physiology | Neurotoxins - pharmacokinetics | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine - pharmacokinetics | Mice | Capillaries - metabolism | Octamer Transcription Factor-1 - metabolism | Dopamine - toxicity | Medical colleges | Amantadine | PET imaging | Analysis | Rodents | Pharmacy | Physiological aspects | Endothelium | Neurochemistry | Drugs | Brain | Dopamine | Toxicity | Index Medicus | Scanning | Confocal microscopy | Oct-2 protein | Endothelial cells | Western blotting | Microdialysis | Blood-brain barrier | MPP super(+) | Neostriatum | Kinetics | MPTP | Positron emission tomography
Journal Article
American Journal of Case Reports, ISSN 1941-5923, 01/2014, Volume 15, pp. 1 - 3
Male, 64 FINAL DIAGNOSIS: Acute Respiratory Distress Syndrome (ARDS) Symptoms: Generalized myoclonic jerks • impaired concentration • memory decline • visual... 
Toxicity | Amantadine | ARDS
Journal Article
Archives of the Spanish Society for Ophthalmology (Archivos de la Sociedad Española de Oftalmología, English Edition), ISSN 2173-5794, 2011, Volume 87, Issue 9, pp. 290 - 293
Abstract Case report A 64 year-old female with Parkinson disease treated with amantadine for two years who suddenly suffered bilateral corneal oedema. It was... 
Ophthalmology | Corneal oedema | Amantadine hydrochloride | Endothelial density | Hidrocloruro de amantadina | Densidad endotelial | Edema corneal
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 11/2013, Volume 56, Issue 22, pp. 9265 - 9274
Journal Article
Archivos de la Sociedad Española de Oftalmologia, ISSN 0365-6691, 2012, Volume 87, Issue 9, pp. 290 - 293
Journal Article
Fundamental & Clinical Pharmacology, ISSN 0767-3981, 10/2011, Volume 25, Issue 5, pp. 608 - 618
A number of experimental models of L ‐DOPA‐induced dyskinesia have been proposed, but these models result in a low to medium rate of dyskinetic animals with... 
rat | 6‐OHDA | DOPA | dyskinesia | Parkinson’s disease | 6-OHDA | Parkinson's disease | Rat | L-DOPA | Dyskinesia | DOPA-INDUCED DYSKINESIA | RISK-FACTORS | LEVODOPA-INDUCED DYSKINESIAS | ROTATIONAL BEHAVIOR | NIGROSTRIATAL FUNCTION | CELLULAR-PARAMETERS | ANIMAL-MODELS | PHARMACOLOGY & PHARMACY | 6-HYDROXYDOPAMINE | MOTOR COMPLICATIONS | PARKINSONS-DISEASE | Single-Blind Method | Antiparkinson Agents - pharmacology | Amantadine - toxicity | Male | Benserazide - pharmacology | Amantadine - therapeutic use | Antiparkinson Agents - therapeutic use | Behavior, Animal | Dopamine - physiology | Dopamine Agents - pharmacology | Dyskinesia, Drug-Induced - drug therapy | Parkinsonian Disorders - drug therapy | Purines - toxicity | Placebos | Adenosine A2 Receptor Antagonists - toxicity | Biological Assay | Purines - therapeutic use | Drug Evaluation, Preclinical | Disease Models, Animal | Levodopa - pharmacology | Reproducibility of Results | Drug Administration Schedule | Purines - pharmacology | Enzyme Inhibitors - pharmacology | Rats | Levodopa - toxicity | Parkinsonian Disorders - chemically induced | Random Allocation | Antiparkinson Agents - adverse effects | Rotation | Sympatholytics - toxicity | Adenosine A2 Receptor Antagonists - pharmacology | Oxidopamine - toxicity | Sample Size | Animals | Levodopa - adverse effects | Corpus Striatum | Dopamine Agents - toxicity | Amantadine - pharmacology | Models | Locomotives | Investigations | Index Medicus
Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 09/2011, Volume 118, Issue 6, pp. 1043 - 1055
Amantadine is the only drug marketed for treating levodopa-induced dyskinesia. However, its impact on basal ganglia circuitry in the dyskinetic brain,... 
substantia nigra | microdialysis | 6‐OHDA | amantadine | levodopa | dyskinesia | 6-OHDA | AMINO-ACID TRANSMISSION | DOPA-INDUCED DYSKINESIA | DUAL PROBE MICRODIALYSIS | BASAL GANGLIA | BIOCHEMISTRY & MOLECULAR BIOLOGY | ABNORMAL INVOLUNTARY MOVEMENTS | NEUROSCIENCES | MESSENGER-RNA LEVELS | NMDA RECEPTOR ANTAGONISTS | STRIATAL SYNAPTIC PLASTICITY | 6-HYDROXYDOPAMINE LESIONED RATS | PARKINSONS-DISEASE | Tyrosine 3-Monooxygenase - metabolism | Data Interpretation, Statistical | Levodopa - antagonists & inhibitors | Antiparkinson Agents - pharmacology | gamma-Aminobutyric Acid - metabolism | Rats | Glutamates - metabolism | Male | Levodopa - toxicity | Substantia Nigra - metabolism | Rats, Sprague-Dawley | Globus Pallidus - drug effects | Sympatholytics - toxicity | Globus Pallidus - metabolism | Substantia Nigra - drug effects | Animals | Hydroxydopamines - toxicity | Microdialysis | Antiparkinson Agents - antagonists & inhibitors | Dyskinesia, Drug-Induced - drug therapy | Parkinson Disease, Secondary - drug therapy | Behavior, Animal - drug effects | Mice | Amantadine - pharmacology | Prevention | Neurosciences | Amantadine | GABA | Dopa | Glutamate | Movement disorders | Drug therapy | Rodents | Index Medicus | Drugs | Brain | Glutamic acid | gamma -Aminobutyric acid | Basal ganglia | Substantia nigra | 6-Hydroxydopamine | Globus pallidus | Amino acids | Data processing | Levodopa | Probes | Dyskinesia
Journal Article
Journal Article
Journal Article
CLINICAL TOXICOLOGY, ISSN 1556-3650, 08/2013, Volume 51, Issue 7, pp. 594 - 595
Conference Proceeding